Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Vlad Coric, M.D.$3.4B
Market Cap • 25/04/20242022
(há 2 anos)
2022
(2 years ago)
NYSE
Listagem
New Haven
Sede • Connecticut202
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
BHVNSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.